Results 121 to 130 of about 489 (130)
Some of the next articles are maybe not open access.
Echocardiographic Changes With Aficamten
Journal of the American College of Cardiologyopenaire +1 more source
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
New England Journal of MedicinePablo Garcia-Pavia +32 more
openaire +1 more source
Aficamten for Obstructive Hypertrophic Cardiomyopathy. Reply.
The New England journal of medicineMartin S, Maron +2 more
openaire +1 more source
SEQUOIA-HCM: Aficamten effects consistent across regions
Medicom Conference Report HFA 2025openaire +1 more source
6ER-008 Aficamten and mavacamten: when side effects affect efficacy
Education and researchAB Pousada Fonseca +2 more
openaire +1 more source
SEQUOIA-HCM: Aficamten demonstrates clinical efficacy in obstructive HCM
Medicom Conference Report HFA 2024openaire +1 more source
SEQUOIA-HCM: Aficamten safe and efficacious for HCM across the globe
Medicom Conference Report HFA 2025openaire +1 more source
Cardiac Myosin Inhibition in Obstructive Hypertrophic Cardiomyopathy: Can Aficamten Stand Alone?
Journal of the American College of CardiologyEnrico, Ammirati, Guglielmo, Gallone
openaire +1 more source
Aficamten in Hypertrophic Cardiomyopathy: Roots and Branches of SEQUOIA.
Journal of the American College of Cardiologyopenaire +1 more source
Echocardiographic Changes With Aficamten: A Pixel Is Worth 1,024 Bits.
Journal of the American College of Cardiologyopenaire +1 more source